Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Regulatory News (AGL)

  • There is currently no data for AGL

Statement re. announcement

11 Jul 2008 13:05

RNS Number : 9056Y
Angle PLC
11 July 2008
 



ANGLE plc

11 July 2008

 

Not for release, publication or distribution in whole or in part, in or into the United States, Canada, Australia, Japan or the Republic of Ireland

 

ANGLE plc ("ANGLE" or the "Company")

 

Statement re. announcement

The Board of ANGLE notes the announcement made today by Braveheart Investment Group plc ("Braveheart"). The Board continues to hold shareholder meetings to discuss its positive Preliminary Results announced yesterday. The Board will make a formal response as soon as reasonably practicable after due consideration. The Board considers that the Braveheart announcement contains a number of factual inaccuracies.

Ends

 

Contact:

 

Andrew Newland, Chief Executive

ANGLE plc

 

+ 44 (0) 1483 295830

 

 

 

Mark Connelly/ Stewart Wallace

Collins Stewart Europe Limited

 

+ 44 (0) 207 523 8350

 

Collins Stewart Europe Limited ("Collins Stewart") which is regulated in the United Kingdom by The Financial Services Authority is acting for the Company in relation to the matters described in this announcement and is not advising any other person, and accordingly will not be responsible to anyone other than the Company for providing the protections afforded to customers of Collins Stewart or for providing advice in relation to the matters described in this announcement.

 

Dealing disclosure requirements

Under the provisions of Rule 8.3 of the City Code on Takeovers and Mergers (the "Code"), if any person is, or becomes, "interested" (directly or indirectly) in 1% or more of any class of "relevant securities" of the Company, all "dealings" in any "relevant securities" of Braveheart or the Company (including by means of an option in respect of, or a derivative referenced to, any such "relevant securities") must be publicly disclosed by no later than 3.30pm (London time) on the London business day following the date of the relevant transaction. This requirement will continue until the date on which the offer becomes, or is declared, unconditional as to acceptances, lapses or is otherwise withdrawn or on which the "offer period" otherwise ends. If two or more persons act together pursuant to an agreement or understanding, whether formal or informal, to acquire an "interest" in "relevant securities" of Braveheart or the Company, they will be deemed to be a single person for the purpose of Rule 8.3.

 

Under the provisions of Rule 8.1 of the Code, all "dealings" in "relevant securities" of Braveheart or the Company or by Braveheart or the Company or by any of their respective "associates", must be disclosed by no later than 12.00 noon (London time) on the London business day following the date of the relevant transaction.

 

A disclosure table, giving details of the companies in whose 'relevant securities' 'dealings' should be disclosed, and the number of such securities in issue, can be found on the Takeover Panel's website at www.thetakeoverpanel.org.uk . 

 

"Interests in securities" arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in price or securities. In particular, a person will be treated as having an "interest" by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

 

Terms in quotation marks are defined in the Code, which can be found on the Panel's website. If you are in any doubt as to whether or not you are required to disclose a "dealing" under Rule 8, you should consult the Panel.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OUPFFLFFVDBEBBV
Date   Source Headline
15th Feb 20105:41 pmRNSHolding(s) in Company
2nd Feb 20101:38 pmRNSHolding(s) in Company
1st Feb 20101:30 pmRNSHolding(s) in Company
29th Jan 20103:14 pmRNSHolding(s) in Company
22nd Jan 20108:49 amRNSHolding(s) in Company
21st Jan 20107:00 amRNSInterim Results
6th Jan 20107:00 amRNSNotice of Interim Results
27th Nov 20097:00 amRNSContract Win
28th Sep 20094:48 pmRNSHolding(s) in Company
24th Sep 20097:40 amRNSDirector/PDMR Shareholding
10th Sep 20093:32 pmRNSResult of AGM
3rd Sep 20094:18 pmRNSHolding(s) in Company
26th Aug 20093:08 pmRNSDisposal of Provexis Holding
12th Aug 20091:40 pmRNSHolding(s) in Company
11th Aug 20094:22 pmRNSHolding(s) in Company
24th Jul 20097:00 amRNSPreliminary Results
2nd Jul 20094:44 pmRNSHolding(s) in Company
11th Jun 20092:21 pmRNSHolding(s) in Company
30th Mar 20095:47 pmRNSDirector/PDMR Shareholding
26th Feb 20097:00 amRNSNovocellus contract completion
11th Feb 20091:44 pmRNSHolding(s) in Company
29th Jan 20097:00 amRNSInterim Results
22nd Jan 20093:09 pmRNSNotice of Results
12th Jan 20097:00 amRNSNovocellus deal
5th Dec 20082:31 pmRNSChange of Registered Address
24th Oct 20084:14 pmRNSAnnual Report & Accounts
22nd Oct 20083:04 pmRNSHolding(s) in Company
12th Sep 20084:43 pmRNSOffer Update
11th Sep 20083:21 pmRNSResult of AGM
11th Sep 20082:46 pmRNSRule 8.3- Angle Plc
10th Sep 200812:48 pmRNSRule 8.3- Angle Plc
5th Sep 20081:23 pmRNSRule 8.3- Angle PLC
28th Aug 200812:51 pmRNSRule 8.3- Angle Plc
27th Aug 20081:05 pmRNSRule 8.3- Angle Plc
22nd Aug 200812:13 pmRNSRule 8.3- Angle Plc
21st Aug 20088:40 amRNSStatement re: Angle Plc
4th Aug 20087:00 amRNSProvexis Fundraising
29th Jul 200811:39 amRNSRule 8.3- Angle Plc
23rd Jul 20082:13 pmRNSRule 8.3- Angle Plc
18th Jul 20085:19 pmRNSRule 2.10 Announcement
18th Jul 20083:09 pmRNSResponse RE Angle Offer
18th Jul 20087:00 amRNSStatement re possible offer
11th Jul 20081:05 pmRNSStatement re. announcement
11th Jul 20088:10 amRNSOffer Update
10th Jul 20087:00 amRNSParsortix world break-through
10th Jul 20087:00 amRNSAguru Images sales
10th Jul 20087:00 amRNSContract Win
10th Jul 20087:00 amRNSPreliminary Results
19th Jun 200811:37 amRNSRule 8.3- Angle Plc
10th Jun 200812:27 pmRNSRule 8.3- Angle Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.